NXD01

N/A

Report date: 2023/11/01 12:05:21
NME

Base Information

Drug NameNXD01
Drug Alias NameNXD01NXD-01
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSerine/threonine-protein kinase WEE1 degraders
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsUterine NeoplasmsOvarian NeoplasmsCarcinoma, Endometrioid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Neox Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Neox Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine NeoplasmsOvarian NeoplasmsCarcinoma, Endometrioid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A